Command Palette

Search for a command to run...

Clinical Trials · NCT05254418

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

CompletedPhase 2Dulaglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Vanderbilt University Medical Center
Enrollment
7
Start date
Mar 2022
Locations
1 site, United States
Primary endpoint
Changes in Intermuscular Fat Deposition as Assessed by Magnetic Resonance Imaging (MRI).
View Dulaglutide compound reference